BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27350391)

  • 1. Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiforme.
    Heiland DH; Mader I; Schlosser P; Pfeifer D; Carro MS; Lange T; Schwarzwald R; Vasilikos I; Urbach H; Weyerbrock A
    Sci Rep; 2016 Jun; 6():29052. PubMed ID: 27350391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme.
    Heiland DH; Simon-Gabriel CP; Demerath T; Haaker G; Pfeifer D; Kellner E; Kiselev VG; Staszewski O; Urbach H; Weyerbrock A; Mader I
    Sci Rep; 2017 Mar; 7():43523. PubMed ID: 28266556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
    Yi L; Tong L; Li T; Hai L; Abeysekera IR; Tao Z; Ma H; Liu P; Xie Y; Li J; Yuan F; Yu S; Yang X
    Mol Med Rep; 2018 Jul; 18(1):741-748. PubMed ID: 29767255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
    Tang C; Guo J; Chen H; Yao CJ; Zhuang DX; Wang Y; Tang WJ; Ren G; Yao Y; Wu JS; Mao Y; Zhou LF
    Int J Clin Exp Pathol; 2015; 8(5):5327-35. PubMed ID: 26191234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
    Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
    J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy.
    Kallenberg K; Bock HC; Helms G; Jung K; Wrede A; Buhk JH; Giese A; Frahm J; Strik H; Dechent P; Knauth M
    Radiology; 2009 Dec; 253(3):805-12. PubMed ID: 19789222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
    Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
    Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
    Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
    J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
    Huang YT; Hsu T; Kelsey KT; Lin CL
    Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    Fatai AA; Gamieldien J
    BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.
    Crawford FW; Khayal IS; McGue C; Saraswathy S; Pirzkall A; Cha S; Lamborn KR; Chang SM; Berger MS; Nelson SJ
    J Neurooncol; 2009 Feb; 91(3):337-51. PubMed ID: 19009235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme.
    Heiland DH; Demerath T; Kellner E; Kiselev VG; Pfeifer D; Schnell O; Staszewski O; Urbach H; Weyerbrock A; Mader I
    Oncotarget; 2017 Feb; 8(7):11083-11093. PubMed ID: 27613830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.